Advertisement
Short communication| Volume 298, ISSUE 1-2, P124-126, November 15, 2010

Download started.

Ok

Posterior reversible encephalopathy syndrome following measles vaccination

Published:September 20, 2010DOI:https://doi.org/10.1016/j.jns.2010.08.054

      Abstract

      Due to recent domestic measles outbreaks in Japan, the Japanese government has mandated measles vaccination at ages 14 and 17 since April 2008. Since then, the number of people receiving measles vaccination has increased in Japan. Measles vaccination may cause serious neurological complications including encephalopathy, although the incidence is very low. We report here an adult case of posterior reversible encephalopathy syndrome (PRES) and myeloradiculoneuropathy following measles vaccination. Brain MRI demonstrated typical findings of PRES, high intensity signals in the occipital lobes on FLAIR imaging, isointensity signals on diffusion weighted imaging, with an increase in the apparent diffusion coefficient (ADC). Vasoconstriction mainly in the posterior cerebral arteries was detected by MRA. Physicians should keep in mind the possible occurrence of PRES and myeloradiculoneuropathy following measles vaccination.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Weibel R.E.
        • Caserta V.
        • Benor D.E.
        • Evans G.
        Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program.
        Pediatrics. 1998; 101: 383-387
        • Gomi H.
        • Takahashi H.
        Why is measles still endemic in Japan?.
        Lancet. 2004; 364: 328-329
        • Bartynski W.S.
        Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.
        AJNR Am J Neuroradiol. 2008; 29: 1043-1049
        • Bartynski W.S.
        Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.
        AJNR Am J Neuroradiol. 2008; 29: 1036-1042
        • Bartynski W.S.
        • Boardman J.F.
        Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome.
        AJNR Am J Neuroradiol. 2008; 29: 447-455
        • Aydin K.
        • Elmas S.
        • Guzes E.A.
        Reversible posterior leukoencephalopathy and Adie's pupil after measles vaccination.
        J Child Neurol. 2006; 21: 525-527
        • Van Diest D.
        • Van Goethem J.W.
        • Vercruyssen A.
        • Jadoul C.
        • Cras P.
        Posterior reversible encephalopathy and Guillain–Barré syndrome in a single patient: coincidence or causative relation?.
        Clin Neurol Neurosurg. 2007; 109: 58-62
        • Tateishi Y.
        • Iguchi Y.
        • Kimura K.
        • Aoki J.
        • Uemura J.
        • Shibazaki K.
        A case of autoimmune thyroid disease presenting posterior reversible encephalopathy syndrome.
        J Neurol Sci. 2008; 271: 203-206
        • Kimura H.
        • Kado H.
        • Koshimoto Y.
        • Tsuchida T.
        • Yonekura Y.
        • Itoh H.
        Multislice continuous arterial spin-labeled perfusion MRI in patients with chronic occlusive cerebrovascular disease: a correlative study with CO2 PET validation.
        J Magn Reson Imaging. 2005; 22: 189-198
        • Grose C.
        • Spigland I.
        Guillain–Barré syndrome following administration of live measles vaccine.
        Am J Med. 1976; 60: 441-443
        • Nakayama T.
        • Onoda K.
        Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
        Vaccine. 2007; 25: 570-576
        • Juurlink D.N.
        • Stukel T.A.
        • Kwong J.
        • Kopp A.
        • McGeer A.
        • Upshur R.E.
        • et al.
        Guillain–Barré syndrome after influenza vaccination in adults: a population-based study.
        Arch Intern Med. 2006; 166: 2217-2221
        • Mihara T.
        • Mutoh T.
        • Yoshikawa T.
        • Yano S.
        • Asano Y.
        • Yamamoto H.
        Postinfectious myeloradiculoneuropathy with cranial nerve involvements associated with human herpesvirus 7 infection.
        Arch Neurol. 2005; 62: 1755-1757
        • Sindern E.
        • Schröder J.M.
        • Krismann M.
        • Malin J.P.
        Inflammatory polyradiculoneuropathy with spinal cord involvement and lethal outcome after hepatitis B vaccination.
        J Neurol Sci. 2001; 186: 81-85
        • Tenembaum S.
        • Chitnis T.
        • Ness J.
        • Hahn J.S.
        Acute disseminated encephalomyelitis.
        Neurology. 2007; 68: S23-S36
        • Bartynski W.S.
        • Upadhyaya A.R.
        • Petropoulou K.A.
        • Boardman J.F.
        Influenza A encephalopathy, cerebral vasculopathy, and posterior reversible encephalopathy syndrome: combined occurrence in a 3-year-old child.
        AJNR Am J Neuroradiol. Dec. 24 2009;
        • Bartynski W.S.
        • Upadhyaya A.R.
        • Boardman J.F.
        Posterior reversible encephalopathy syndrome and cerebral vasculopathy associated with influenza A infection: report of a case and review of the literature.
        J Comput Assist Tomogr. 2009; 33: 917-922
        • Horbinski C.
        • Bartynski W.S.
        • Carson-Walter E.
        • Hamilton R.L.
        • Tan H.P.
        • Cheng S.
        Reversible encephalopathy after cardiac transplantation: histologic evidence of endothelial activation, T-cell specific trafficking, and vascular endothelial growth factor expression.
        AJNR Am J Neuroradiol. 2009; 30: 588-590